Each one in plain English, with the numbers worked through for a shareholder.
1 Oct 2020annual report▼ Bad
Audited FY20 accounts: net assets fell $6.55m to $93.73m. Sales rose 5.7% to $8.43m; China tariffs added $1.159m of costs. Donald model update planned for late 2020 with a resource update. Confirms the preliminary figures.
Unaudited year to June 2020: revenue up 6.9% to $8.78m, loss after tax widened to $6.29m, NTA fell 34% to 12.4 cps. Operating cash outflow narrowed to $2.13m. Donald pilot plant trials completed; Niafarang development continues.
31 July 2020quarterly activities report▲ GoodMajor
June 2020 quarter: Donald spend $287k (FY $900k), Niafarang $54k. The China plant produced 2,923t of rutile, up 354%, and sold 3,372t, up 1077% on the prior quarter. Donald feasibility update still 'shortly'; funding unresolved.
Astron clarifies that the Donald Ore Reserve from the 2013 feasibility study remains materially the same, and that omitting it from recent annual reports was an oversight. The April 2016 resource is the latest. No new reserve can be given until design and costs are finalised.
ICSID rejected The Gambia's annulment application in full and lifted the stay on enforcing the award (about A$31m, from 2015). Astron will explore enforcement options. This resolves the annulment thread; actual collection is not yet shown.
Pilot of 1,000t of Donald ore in a four-stage plant in Queensland, run by Mineral Technologies, was completed and Astron is pleased with it. Total TiO2, ZrO2 and CeO2 recovery to sand was 85.2%, 94.6% and 95.9%. About 24t of concentrate was produced. Supports the planned process design.
March 2020 quarter: no production. Donald spend $122k, Niafarang $141k. Feasibility update still 'shortly' and funding unresolved. New: Astron is assessing COVID-19 delays to service availability affecting Donald.
Half-year to December 2019: revenue up 20.9% to $5.28m, net loss widened to $2.44m, NTA $0.24 per share. Cash rose $1.35m to $3.04m. The auditor again includes a going-concern emphasis of matter.
ASX suspended Astron from quotation from 2 March 2020 for failing to lodge its half-year report by the due date. The suspension is a routine compliance step, lifted once the report is filed.
Astron says its half-year report, due 28 February 2020, is delayed, partly because its Yingkou office was shut for three weeks under COVID-19 rules. Trading will stay suspended until the report is lodged. This likely explains the 2 December 2019 pause is not stated.
Astron says commissioning of its Yingkou TiO2 plant (up to 150,000tpa) is complete, ahead of milestones. The plant runs at about 65% capacity, processing 15,000t of feed a month into 3,000-5,000t of product. This ends the extended commissioning thread; a throughput update is promised.
December 2019 quarter: no production. Donald spend $314k, Niafarang $69k. Piloting continues, feasibility update still 'shortly'. Funding is still being considered; the CMEC discussion mention is dropped. Niafarang start date is not restated.
Managing Director Alex Brown, long-time driving force of Astron, died on 30 November 2019. Kang Rong, previously COO and Deputy MD, becomes CEO and Managing Director. Tiger Brown, son of Alex Brown and Kang Rong, joins the board; board structure to be reviewed.
ASX paused trading in Astron securities pending a further announcement. No reason is given in the notice. It follows the earlier Oct 2018 pause, whose reason was also not stated.
Cover note releasing the FY2019 annual report, which accompanies the statutory accounts released 1 October 2019. Says Hong Kong company Astron need not publish one. Administrative; no new company information.
FY2019 annual report: Chairman says the China plant is producing high-purity TiO2 feedstock with rising sales. The 1,000t Donald bulk sample piloting is complete, with a 30t concentrate going to China. Donald funding options are still being explored. Text is truncated.
September 2019 quarter: no production. Donald spend $177k, Niafarang $68k. Donald piloting continues in southern Queensland; feasibility update still 'shortly' and funding unresolved, with CMEC talks continuing. Niafarang start now targeted late 2019. China plant in extended commissioning.
Statutory FY2019 accounts: net assets up $466k to $100.27m, no dividend. Donald water pipeline now about 13km from Minyip, versus the earlier 75km. Sales revenue $7.98m; NTA 18.8cps, down from 20.6cps.
Unaudited FY2019: sales revenue up 59.1% to $7.98m, loss after tax $1.91m, NTA down 8.5% to 18.8cps. Operating cash outflow was $6.94m. The China plant was commissioned using US ilmenite feedstock.
June 2019 quarter: no production. Donald spend $910k (FY $1.39m), up on prior quarters, as piloting began; Niafarang $176k. Feasibility update still 'shortly'; funding unresolved. China plant is in extended commissioning.
Astron began a three-stage piloting program on Donald ore, with a 10 tonne per hour pilot plant under construction in Australia. Aims to define final products. It does not address the unresolved Donald funding.
Astron began commissioning its China TiO2 processing plant, built for up to 150,000tpa, delivering the plant contracted in April 2018. Customers have pre-sale arrangements and orders are being filled during commissioning. No throughput or revenue figures given.
March 2019 quarter: no production. Donald spend $244k, Niafarang $36k. Donald feasibility update and funding unchanged from before. Niafarang start still targeted 'in 2019'. About 55,000t TiO2 feedstock held; plant commissioning continues.
FY2018 annual report: the China processing plant (up to 150,000tpa) is complete, with commissioning begun January 2019. Donald construction awaits financing milestones; Astron is renting a pilot plant and investigating funding. Niafarang equipment is delivered; focus is on rutile production and Niafarang.
Cover note releasing the FY2018 annual report, which accompanies the statutory accounts released 1 October 2018. Explains that as a Hong Kong company Astron is not required to publish it. Administrative.
Half-year to December 2018: revenue up 168.2% to $4.37m, net loss $945k, NTA 19cps. The auditor's review includes a going-concern emphasis of matter. Cash and term deposits fell $1.76m, partly offset by about $5.1m bank loans and $3.09m land-sale receipts.
December 2018 quarter: no production. Donald spend $132k, Niafarang $143k. Feasibility update still 'shortly' and no Donald funding resolved. Niafarang target is now just 'in 2019'. TiO2 feedstock acquired has grown to about 55,000t. EL5186 transferred to DMS.